GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (FRA:0PQ) » Definitions » Price-to-Operating-Cash-Flow

ProQR Therapeutics NV (FRA:0PQ) Price-to-Operating-Cash-Flow : (As of Dec. 15, 2024)


View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV Price-to-Operating-Cash-Flow?

As of today (2024-12-15), ProQR Therapeutics NV's share price is €3.072. ProQR Therapeutics NV's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.40. Hence, ProQR Therapeutics NV's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for ProQR Therapeutics NV's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 12 years, ProQR Therapeutics NV's highest Price-to-Operating-Cash-Flow Ratio was 22.87. The lowest was 6.87. And the median was 10.73.

FRA:0PQ's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.685
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

ProQR Therapeutics NV's Cash Flow from Operations per share for the three months ended in Sep. 2024 was €-0.07. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.40.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of ProQR Therapeutics NV was -559.60% per year.

During the past 12 years, ProQR Therapeutics NV's highest 3-Year average Operating Cash Flow per Share Growth Rate was 21.60% per year. The lowest was -120.60% per year. And the median was 5.60% per year.


ProQR Therapeutics NV Price-to-Operating-Cash-Flow Historical Data

The historical data trend for ProQR Therapeutics NV's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProQR Therapeutics NV Price-to-Operating-Cash-Flow Chart

ProQR Therapeutics NV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 6.83

ProQR Therapeutics NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.83 6.83 - - -

Competitive Comparison of ProQR Therapeutics NV's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, ProQR Therapeutics NV's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProQR Therapeutics NV's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProQR Therapeutics NV's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ProQR Therapeutics NV's Price-to-Operating-Cash-Flow falls into.



ProQR Therapeutics NV Price-to-Operating-Cash-Flow Calculation

ProQR Therapeutics NV's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=3.072/-0.398
=

ProQR Therapeutics NV's Share Price of today is €3.072.
ProQR Therapeutics NV's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.40.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

ProQR Therapeutics NV Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of ProQR Therapeutics NV's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


ProQR Therapeutics NV Business Description

Traded in Other Exchanges
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

ProQR Therapeutics NV Headlines

No Headlines